OpenURL Connection Search

Select item for more details and to access through your institution.

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Published in:
2001
By:
- Epstein, Joel B.;
- Silverman, Sol;
- Paggiarino, Dario A.;
- Crockett, Steve;
- Schubert, Mark M.;
- Senzer, Neil N.;
- Lockhart, Peter B.;
- Gallagher, Michael J.;
- Peterson, Douglas E.;
- Leveque, Francis G.;
- Epstein, J B;
- Silverman, S Jr;
- Paggiarino, D A;
- Crockett, S;
- Schubert, M M;
- Senzer, N N;
- Lockhart, P B;
- Gallagher, M J;
- Peterson, D E;
- Leveque, F G
Publication type:
journal article
Phase 1 study of N(1),N(11)diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
Published in:
2013
By:
- Goyal, Lipika;
- Supko, Jeffrey G;
- Berlin, Jordan;
- Blaszkowsky, Lawrence S;
- Carpenter, Amanda;
- Heuman, Douglas M;
- Hilderbrand, Sarah L;
- Stuart, Keith E;
- Cotler, Scott;
- Senzer, Neil N;
- Chan, Emily;
- Berg, Carl L;
- Clark, Jeffrey W;
- Hezel, Aram F;
- Ryan, David P;
- Zhu, Andrew X
Publication type:
Journal Article
Phase 1 study of N1,N11-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1305, doi. 10.1007/s00280-013-2293-8
By:
- Goyal, Lipika;
- Supko, Jeffrey G.;
- Berlin, Jordan;
- Blaszkowsky, Lawrence S.;
- Carpenter, Amanda;
- Heuman, Douglas M.;
- Hilderbrand, Sarah L.;
- Stuart, Keith E.;
- Cotler, Scott;
- Senzer, Neil N.;
- Chan, Emily;
- Berg, Carl L.;
- Clark, Jeffrey W.;
- Hezel, Aram F.;
- Ryan, David P.;
- Zhu, Andrew X.
Publication type:
Article
Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy.
Published in:
Drug Target Insights, 2008, n. 3, p. 55, doi. 10.4137/DTI.S649
By:
- Shen, Yuqiao;
- Senzer, Neil N.;
- Nemunaitis, John J.
Publication type:
Article

Found: 4

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Phase 1 study of N(1),N(11)diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Phase 1 study of <i>N</i><sup>1</sup>,<i>N</i><sup>11</sup>-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy.